dc.contributor.author |
Mohanrasu, K
|
|
dc.contributor.author |
Siva Prakash, G
|
|
dc.contributor.author |
Boobalan, T
|
|
dc.contributor.author |
Ananthi, V
|
|
dc.contributor.author |
Dinesh, GH
|
|
dc.contributor.author |
Anand, K
|
|
dc.contributor.author |
Muniyasamy, Sudhakar
|
|
dc.contributor.author |
Chuturgoon, A
|
|
dc.contributor.author |
Arun, A
|
|
dc.contributor.editor |
Krishnan, A |
|
dc.contributor.editor |
Chuturgoon, A |
|
dc.date.accessioned |
2021-02-17T18:46:43Z |
|
dc.date.available |
2021-02-17T18:46:43Z |
|
dc.date.issued |
2020-01 |
|
dc.identifier.citation |
Mohanrasu, K., Siva Prakash, G., Boobalan, T., Ananthi, V., Dinesh, G., Anand, K., Muniyasamy, S. & Chuturgoon, A. et al. 2020. Synthetic, natural derived lipid nanoparticles and polymeric nanoparticles drug delivery applications. In <i>Integrative Nanomedicine for New Therapies</i>. A. Krishnan & A. Chuturgoon, Eds. S.l.: Springer. http://hdl.handle.net/10204/11785 . |
en_ZA |
dc.identifier.isbn |
978-3-030-36260-7 |
|
dc.identifier.uri |
http://hdl.handle.net/10204/11785
|
|
dc.description.abstract |
In modern therapeutic field, the delivery to the desired site is a crucial bottleneck that needs to be addressed for efficacy and potency of the administrated drug. The recent advancements in the field of nanotechnology has enabled researchers to deliver the drug and other diagnostic agents without unfavourabel effect in huma. Though drug delivery system (DDS) is highly advanatageous, the clinical success rate depends on the appropriate carrier molecules which precisely recognise the target site for the release of drug and its biocompatibility. To overcome this concern both synthetic and naturally derived liip-based nano carriers are the preeminent option as it is biocompatible, non-toxic, enhances the bioavailabity of poorly absorbed drugs, drug release modulation flexibility, improved drug loading capacity and stability. |
en_US |
dc.format |
Abstract |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Springer |
en_US |
dc.relation.uri |
https://www.springer.com/gp/book/9783030362591 |
en_US |
dc.relation.uri |
https://doi.org/10.1007/978-3-030-36260-7_6 |
en_US |
dc.source |
Integrative Nanomedicine for New Therapies |
en_US |
dc.subject |
Lipid nanoparticles |
en_US |
dc.subject |
Polymer nanoparticles |
en_US |
dc.subject |
Synthetic |
en_US |
dc.subject |
Naturally derived |
en_US |
dc.subject |
Drug delivery |
en_US |
dc.title |
Synthetic, natural derived lipid nanoparticles and polymeric nanoparticles drug delivery applications |
en_US |
dc.type |
Book Chapter |
en_US |
dc.description.pages |
147-165 |
en_US |
dc.description.placeofpublication |
Cham, Switzerland |
en_US |
dc.description.note |
© Springer Nature Switzerland AG 2020. Due to copyright restrictions, the attached PDF file contains the abstract of the full-text item. For access to the full-text item, please consult the publisher's website: https://doi.org/10.1007/978-3-030-36260-7_6 |
en_US |
dc.description.cluster |
Chemicals |
en_US |
dc.description.impactarea |
Advanced Polymer Composites |
en_US |
dc.identifier.apacitation |
Mohanrasu, K., Siva Prakash, G., Boobalan, T., Ananthi, V., Dinesh, G., Anand, K., ... Arun, A. (2020). Synthetic, natural derived lipid nanoparticles and polymeric nanoparticles drug delivery applications. In A. Krishnan & A. Chuturgoon. (Eds.), <i>Integrative Nanomedicine for New Therapies</i> Springer. http://hdl.handle.net/10204/11785 |
en_ZA |
dc.identifier.chicagocitation |
Mohanrasu, K, G Siva Prakash, T Boobalan, V Ananthi, GH Dinesh, K Anand, Sudhakar Muniyasamy, A Chuturgoon, and A Arun. "Synthetic, natural derived lipid nanoparticles and polymeric nanoparticles drug delivery applications" In <i>INTEGRATIVE NANOMEDICINE FOR NEW THERAPIES</i>, edited by A Krishnan. n.p.: Springer. 2020. http://hdl.handle.net/10204/11785. |
en_ZA |
dc.identifier.vancouvercitation |
Mohanrasu K, Siva Prakash G, Boobalan T, Ananthi V, Dinesh G, Anand K, et al. Synthetic, natural derived lipid nanoparticles and polymeric nanoparticles drug delivery applications. In Krishnan A, Chuturgoon A, editors.. Integrative Nanomedicine for New Therapies. [place unknown]: Springer; 2020. [cited yyyy month dd]. http://hdl.handle.net/10204/11785. |
en_ZA |
dc.identifier.ris |
TY - Book Chapter
AU - Mohanrasu, K
AU - Siva Prakash, G
AU - Boobalan, T
AU - Ananthi, V
AU - Dinesh, GH
AU - Anand, K
AU - Muniyasamy, Sudhakar
AU - Chuturgoon, A
AU - Arun, A
AB - In modern therapeutic field, the delivery to the desired site is a crucial bottleneck that needs to be addressed for efficacy and potency of the administrated drug. The recent advancements in the field of nanotechnology has enabled researchers to deliver the drug and other diagnostic agents without unfavourabel effect in huma. Though drug delivery system (DDS) is highly advanatageous, the clinical success rate depends on the appropriate carrier molecules which precisely recognise the target site for the release of drug and its biocompatibility. To overcome this concern both synthetic and naturally derived liip-based nano carriers are the preeminent option as it is biocompatible, non-toxic, enhances the bioavailabity of poorly absorbed drugs, drug release modulation flexibility, improved drug loading capacity and stability.
DA - 2020-01
DB - ResearchSpace
DP - CSIR
ED - Krishnan, A
ED - Chuturgoon, A
J1 - Integrative Nanomedicine for New Therapies
KW - Lipid nanoparticles
KW - Polymer nanoparticles
KW - Synthetic
KW - Naturally derived
KW - Drug delivery
LK - https://researchspace.csir.co.za
PY - 2020
SM - 978-3-030-36260-7
T1 - Synthetic, natural derived lipid nanoparticles and polymeric nanoparticles drug delivery applications
TI - Synthetic, natural derived lipid nanoparticles and polymeric nanoparticles drug delivery applications
UR - http://hdl.handle.net/10204/11785
ER - |
en_ZA |
dc.identifier.worklist |
24152 |
en_US |